254 related articles for article (PubMed ID: 15048729)
1. The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils.
Zhang JQ; Biedermann B; Nitschke L; Crocker PR
Eur J Immunol; 2004 Apr; 34(4):1175-84. PubMed ID: 15048729
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters.
Angata T; Hingorani R; Varki NM; Varki A
J Biol Chem; 2001 Nov; 276(48):45128-36. PubMed ID: 11579105
[TBL] [Abstract][Full Text] [Related]
3. mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2.
Yu Z; Maoui M; Wu L; Banville D; Shen S
Biochem J; 2001 Feb; 353(Pt 3):483-92. PubMed ID: 11171044
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of human Siglec-8 orthologs relevant to mouse eosinophils: identification of mouse orthologs of Siglec-5 (mSiglec-F) and Siglec-10 (mSiglec-G).
Aizawa H; Zimmermann N; Carrigan PE; Lee JJ; Rothenberg ME; Bochner BS
Genomics; 2003 Nov; 82(5):521-30. PubMed ID: 14559209
[TBL] [Abstract][Full Text] [Related]
5. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.
Bochner BS
Clin Exp Allergy; 2009 Mar; 39(3):317-24. PubMed ID: 19178537
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors.
Zhang J; Raper A; Sugita N; Hingorani R; Salio M; Palmowski MJ; Cerundolo V; Crocker PR
Blood; 2006 May; 107(9):3600-8. PubMed ID: 16397130
[TBL] [Abstract][Full Text] [Related]
7. Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.
Legrand F; Cao Y; Wechsler JB; Zhu X; Zimmermann N; Rampertaap S; Monsale J; Romito K; Youngblood BA; Brock EC; Makiya MA; Tomasevic N; Bebbington C; Maric I; Metcalfe DD; Bochner BS; Klion AD
J Allergy Clin Immunol; 2019 Jun; 143(6):2227-2237.e10. PubMed ID: 30543818
[TBL] [Abstract][Full Text] [Related]
8. Studies on the Detection, Expression, Glycosylation, Dimerization, and Ligand Binding Properties of Mouse Siglec-E.
Siddiqui S; Schwarz F; Springer S; Khedri Z; Yu H; Deng L; Verhagen A; Naito-Matsui Y; Jiang W; Kim D; Zhou J; Ding B; Chen X; Varki N; Varki A
J Biol Chem; 2017 Jan; 292(3):1029-1037. PubMed ID: 27920204
[TBL] [Abstract][Full Text] [Related]
9. Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils.
Zhang M; Angata T; Cho JY; Miller M; Broide DH; Varki A
Blood; 2007 May; 109(10):4280-7. PubMed ID: 17272508
[TBL] [Abstract][Full Text] [Related]
10. "Siglec"ting the allergic response for therapeutic targeting.
Bochner BS
Glycobiology; 2016 Jun; 26(6):546-52. PubMed ID: 26911285
[TBL] [Abstract][Full Text] [Related]
11. Siglec-8 and Siglec-F, the new therapeutic targets in asthma.
Farid SSh; Mirshafiey A; Razavi A
Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):721-6. PubMed ID: 22324980
[TBL] [Abstract][Full Text] [Related]
12. Frontline Science: Superior mouse eosinophil depletion in vivo targeting transgenic Siglec-8 instead of endogenous Siglec-F: Mechanisms and pitfalls.
Knuplez E; Krier-Burris R; Cao Y; Marsche G; O'Sullivan J; Bochner BS
J Leukoc Biol; 2020 Jul; 108(1):43-58. PubMed ID: 32134149
[TBL] [Abstract][Full Text] [Related]
13. Sialic acid-binding immunoglobulin-like lectin 8 (Siglec-8) is an activating receptor mediating β
Carroll DJ; O'Sullivan JA; Nix DB; Cao Y; Tiemeyer M; Bochner BS
J Allergy Clin Immunol; 2018 Jun; 141(6):2196-2207. PubMed ID: 28888781
[TBL] [Abstract][Full Text] [Related]
14. Viewing Siglecs through the lens of tumor immunology.
Fraschilla I; Pillai S
Immunol Rev; 2017 Mar; 276(1):178-191. PubMed ID: 28258691
[TBL] [Abstract][Full Text] [Related]
15. Sialyltransferase ST3Gal-III regulates Siglec-F ligand formation and eosinophilic lung inflammation in mice.
Suzukawa M; Miller M; Rosenthal P; Cho JY; Doherty TA; Varki A; Broide D
J Immunol; 2013 Jun; 190(12):5939-48. PubMed ID: 23677475
[TBL] [Abstract][Full Text] [Related]
16. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33.
Whitney G; Wang S; Chang H; Cheng KY; Lu P; Zhou XD; Yang WP; McKinnon M; Longphre M
Eur J Biochem; 2001 Dec; 268(23):6083-96. PubMed ID: 11733002
[TBL] [Abstract][Full Text] [Related]
17. Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand.
Tateno H; Crocker PR; Paulson JC
Glycobiology; 2005 Nov; 15(11):1125-35. PubMed ID: 15972893
[TBL] [Abstract][Full Text] [Related]
18. Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily.
Floyd H; Ni J; Cornish AL; Zeng Z; Liu D; Carter KC; Steel J; Crocker PR
J Biol Chem; 2000 Jan; 275(2):861-6. PubMed ID: 10625619
[TBL] [Abstract][Full Text] [Related]
19. A Sulfonamide Sialoside Analogue for Targeting Siglec-8 and -F on Immune Cells.
Nycholat CM; Duan S; Knuplez E; Worth C; Elich M; Yao A; O'Sullivan J; McBride R; Wei Y; Fernandes SM; Zhu Z; Schnaar RL; Bochner BS; Paulson JC
J Am Chem Soc; 2019 Sep; 141(36):14032-14037. PubMed ID: 31460762
[TBL] [Abstract][Full Text] [Related]
20. Human Siglec-5: tissue distribution, novel isoforms and domain specificities for sialic acid-dependent ligand interactions.
Connolly NP; Jones M; Watt SM
Br J Haematol; 2002 Oct; 119(1):221-38. PubMed ID: 12358929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
